| Benefits and harms of breast cancer screening: a systematic review ER Myers, P Moorman, JM Gierisch, LJ Havrilesky, LJ Grimm, S Ghate, ... Jama 314 (15), 1615-1634, 2015 | 733 | 2015 |
| Recurrence rates in patients with cervical cancer treated with abdominal versus minimally invasive radical hysterectomy: a multi-institutional retrospective review study S Uppal, PA Gehrig, K Peng, KL Bixel, K Matsuo, MH Vetter, BA Davidson, ... Journal of Clinical Oncology 38 (10), 1030-1040, 2020 | 153 | 2020 |
| New therapies for advanced, recurrent, and metastatic endometrial cancers V Makker, AK Green, RM Wenham, D Mutch, B Davidson, DS Miller Gynecologic oncology research and practice 4, 1-12, 2017 | 97 | 2017 |
| The INTUIT study: investigating neuroinflammation underlying postoperative cognitive dysfunction M Berger, D Oyeyemi, MO Olurinde, HE Whitson, KJ Weinhold, ... Journal of the American Geriatrics Society 67 (4), 794-798, 2019 | 49 | 2019 |
| Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma AE Veade, J Foote, J Ehrisman, G Broadwater, BA Davidson, PS Lee, ... World Journal of Surgical Oncology 17, 1-8, 2019 | 32 | 2019 |
| Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: an ancillary data analysis of the NRG Oncology/Gynecologic Oncology … NT Phippen, AA Secord, S Wolf, G Samsa, B Davidson, AP Abernethy, ... Gynecologic oncology 147 (1), 98-103, 2017 | 32 | 2017 |
| Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer BA Davidson, AA Secord International journal of women's health, 289-300, 2014 | 30 | 2014 |
| Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies SL Gaillard, KJ Andreano, LM Gay, M Steiner, MS Jorgensen, ... Gynecologic oncology 154 (1), 199-206, 2019 | 27 | 2019 |
| Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer JR Salinaro, K McQuillen, M Stemple, R Boccaccio, J Ehrisman, ... International Journal of Gynecologic Cancer 30 (4), 2020 | 26 | 2020 |
| Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis BB Albright, KA Monuszko, SJ Kaplan, BA Davidson, HA Moss, AB Huang, ... American journal of obstetrics and gynecology 225 (3), 237. e1-237. e24, 2021 | 24 | 2021 |
| Recurrence rates in cervical cancer patients treated with abdominal versus minimally invasive radical hysterectomy: A multi-institutional analysis of 700 cases. S Uppal, P Gehrig, MH Vetter, BA Davidson, BF Lees, LL Brunette, ... Journal of Clinical Oncology 37 (15_suppl), 5504-5504, 2019 | 24 | 2019 |
| Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer LJ Havrilesky, JC Yang, PS Lee, AA Secord, JA Ehrisman, B Davidson, ... Cancer 125 (24), 4399-4406, 2019 | 22 | 2019 |
| Tumor grade and chemotherapy response in endometrioid endometrial cancer BA Davidson, J Foote, LH Clark, G Broadwater, J Ehrisman, P Gehrig, ... Gynecologic Oncology Reports 17, 3-6, 2016 | 22 | 2016 |
| A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging surgery CH Watson, M Lopez-Acevedo, G Broadwater, AH Kim, J Ehrisman, ... Gynecologic oncology 153 (2), 399-404, 2019 | 21 | 2019 |
| Gender trends in gynecologic oncology authorship: implications for the critical evaluation of gender distribution in academic rank and leadership positions JR Salinaro, AM Puechl, LJ Havrilesky, BA Davidson Gynecologic Oncology 151 (3), 542-546, 2018 | 21 | 2018 |
| Symptoms of women with high-risk early-stage ovarian cancer JK Chan, C Tian, JP Kesterson, BJ Monk, DS Kapp, B Davidson, ... Obstetrics & Gynecology 139 (2), 157-162, 2022 | 20 | 2022 |
| Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy BA Davidson, G Broadwater, A Crim, R Boccacio, K Bixel, F Backes, ... Gynecologic Oncology 152 (3), 554-559, 2019 | 19 | 2019 |
| Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer AA Secord, M McCollum, BA Davidson, G Broadwater, R Squatrito, ... Gynecologic Oncology 153 (3), 555-561, 2019 | 18 | 2019 |
| Risk–benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer BA Davidson, PG Moorman Expert opinion on drug safety 13 (10), 1375-1382, 2014 | 18 | 2014 |
| Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers S Russo, JL Walker, JW Carlson, J Carter, LC Ward, A Covens, ... Gynecologic oncology 160 (2), 625-632, 2021 | 17 | 2021 |
